VIRX

Viracta Therapeutics, Inc. VIRX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VIRX RSPI BICTF CBDG ENMI WSNAF OTRKQ BIOAF LVVEF TCNAF
6M -51.10 % -42.11 % 614.29 % 78.08 % -95.65 % -13.38 % -96.53 % -50.00 % 0.00 % 0.00 %
YTD -94.47 % 37.50 % -98.41 % 75.68 % -98.80 % 18.67 % -97.36 % 100.00 % 0.00 % 0.00 %
1Y -95.61 % -31.25 % -98.41 % 109.68 % -98.18 % 223.64 % -97.86 % 100.00 % 0.00 % 0.00 %
3Y -99.75 % -88.30 % -90.45 % -90.72 % -97.96 % -74.68 % -99.87 % -99.81 % -91.47 % -99.09 %
5Y -99.79 % -98.51 % -99.25 % -83.54 % -98.89 % -99.19 % -100.00 % -99.93 % -99.92 % -99.99 %
10Y -99.99 % -100.00 % -99.73 % -98.16 % -80.00 % -99.19 % -99.95 % -99.98 % -99.92 % -99.99 %
From the beginning -100.00 % -100.00 % -99.73 % -95.67 % -99.90 % -99.19 % -100.00 % -99.97 % -99.92 % -99.99 %

Dividend